Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyAntigens, CD34Hematologic NeoplasmsBlood Component RemovalStem Cell TransplantationCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsGraft vs Host DiseaseBusulfanHematopoietic Stem CellsTreatment OutcomeLymphoma, Non-HodgkinBone Marrow TransplantationGraft SurvivalEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineIfosfamideHematopoiesisSalvage TherapyVincristineAmyloidosisStem CellsCytarabineHodgkin DiseaseCord Blood Stem Cell TransplantationDisease-Free SurvivalTransplantation ChimeraRetrospective StudiesNeoplasmsTissue DonorsSurvival RateWhole-Body IrradiationSurvival AnalysisTime FactorsInfectionLymphoma, T-CellDoxorubicinHistocompatibilityPOEMS SyndromePlatelet CountHistocompatibility TestingCarboplatinPrednisoneImmunosuppressive AgentsLeukemia, Myeloid, AcuteVidarabineTransplantation, IsogeneicLeukemiaDexamethasoneRecombinant ProteinsBlood Cell CountFollow-Up StudiesBlood CellsAntineoplastic AgentsLymphomaBone Marrow PurgingCytomegalovirus InfectionsGraft vs Leukemia EffectProspective StudiesFatal OutcomeFeasibility StudiesMyelodysplastic SyndromesImmunophenotypingAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone MarrowBlood Transfusion, AutologousLiver TransplantationLymphocyte DepletionT-LymphocytesLeukocytes, MononuclearHematologic DiseasesPrecursor Cell Lymphoblastic Leukemia-LymphomaHLA AntigensHistiocytosis, Non-Langerhans-CellLivedo ReticularisOpportunistic InfectionsPrognosisCyclosporineBreast NeoplasmsFlow CytometryBlood DonorsCell SeparationImmunosuppression